Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
SHEZF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $625 | -$802 | $715 | $233 |
| Dep. & Amort. | $331 | $374 | $308 | $303 |
| Deferred Tax | $0 | $0 | -$43 | -$171 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $1,203 | -$801 | -$2,311 | -$1,125 |
| Other Non-Cash | $35 | $1,627 | $532 | $582 |
| Operating Cash Flow | $2,194 | $398 | -$757 | -$7 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$203 | -$445 | -$222 | -$194 |
| Net Acquisitions | $0 | $0 | $3 | $2 |
| Inv. Purchases | -$2,158 | -$677 | -$4,483 | -$2,370 |
| Inv. Sales/Matur. | $2,108 | $1,647 | $4,211 | $3,305 |
| Other Inv. Act. | -$162 | $696 | $742 | -$23 |
| Investing Cash Flow | -$415 | $1,222 | $250 | $720 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1,966 | -$882 | $594 | -$73 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$160 | -$426 | -$51 | -$220 |
| Other Fin. Act. | -$13 | $98 | -$14 | -$16 |
| Financing Cash Flow | -$2,140 | -$1,210 | $330 | -$501 |
| Forex Effect | $17 | $36 | $17 | -$63 |
| Net Chg. in Cash | -$344 | $446 | -$160 | $149 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,766 | $1,320 | $1,480 | $1,330 |
| End Cash | $1,422 | $1,766 | $1,320 | $1,480 |
| Free Cash Flow | $1,991 | -$47 | -$979 | -$200 |